For
UK
audiences
The professional's guide to product selection
The professional's guide to product selection
A non-specific adrenoceptor agonist.
By mouth for reversible airway obstruction
• Adult: 15–60 mg, three times daily
By intranasal administration for nasal congestion and sinusitis affecting the maxillary atrum
• Child 12-17 years: Apply 1–2 drops up to 4 times a day as required for a maximum of 7 days, to be instilled into each nostril, administer ephedrine 0.5% nasal drops.
• Adult: Apply 1–2 drops up to 4 times a day as required for a maximum of 7 days, to be instilled into each nostril.
For the management of reversible airways obstruction.
Ephedrine is less suitable and less safe for use as a bronchodilator than the selective beta2 agonists, because it is more likely to cause arrhythmias and other side-effects. It should be avoided if possible.
Avoid use in the case of renal impairment, pregnancy and breast feeding.
Tablet
Tablets
15 mg, pack of 28
30 mg, pack of 28
Antimuscarinic bronchodilator.
• Over 18 years for maintenance of COPD: by inhalation of powder, one capsule, once daily.
Long-acting selective beta2 agonist with corticosteroid.
Prophylaxis of moderate-to-severe asthma for Aloflute® 25/125 by inhalation of aerosol
Adult: 2 inhalations twice daily.
Prophylaxis of moderate-to-severe asthma for Aloflute® 25/250 by inhalation of aerosol
Adult: 2 inhalations twice daily.
Long-acting selective beta2 agonist with long-acting muscarinic antagonist.
Adult: one inhalation twice daily.
Antimuscarinic bronchodilator.
• Over 18 years: by inhalation of powder, 375 mcg (1 inhalation), twice daily.
Short-acting selective beta2 agonist.
For acute bronchospasm, Salbulin Novolizer® by inhalation of powder
Adult: Initially 100–200 micrograms, up to 800 micrograms daily for persistent symptoms.
For prophylaxis of allergen- or exercise-induced bronchospasm, Salbulin Novolizer® by inhalation of powder
Adult: 200 micrograms.
Short-acting selective beta2 agonist.
Oral
(Please note, inhalation route preferred over oral route in children.)
• Child 1 month–1 year: 100 mcg/kg (maximum 2 mg) 3–4 times daily
• Child 2–5 years: 1–2 mg, 3–4 times daily
• Child 6–11 years: 2 mg, 3–4 times daily
• Child 12–17 years: 2–4 mg, 3–4 times daily
• Over 18 years: 4 mg (elderly and sensitive patients initially 2 mg), 3–4 times daily, with a maximum single dose of 8 mg (but unlikely to provide much extra benefit or to be tolerated).
Moderate to severe or life-threatening acute asthma, treated by inhalation of nebulised solution. Give via a large volume spacer, and via a close-fitting face mask in children under 3 years.
• Child 1 month–4 years: 2.5 mg, repeat every 20–30 minutes or when required.
• Child 5–11 years: 2.5–5 mg, repeat every 20–30 minutes or when required.
• Over 12 years: 5 mg, repeat every 20–30 minutes or when required.
A non-specific adrenoceptor agonist.
By mouth for reversible airway obstruction
• Adult: 15–60 mg, three times daily
By intranasal administration for nasal congestion, sinusitis affecting the maxillary antrum
• Over 12 years: apply 1–2 drops up to four times per day in each nostril for a maximum of seven days
A non-specific adrenoceptor agonist.
By mouth for reversible airway obstruction
• Adult: 15–60 mg, three times daily
By intranasal administration for nasal congestion, sinusitis affecting the maxillary antrum
• Over 12 years: apply 1–2 drops up to four times per day in each nostril for a maximum of seven days
A non-specific adrenoceptor agonist.
By mouth for reversible airway obstruction
• Adult: 15–60 mg, three times daily
By intranasal administration for nasal congestion and sinusitis affecting the maxillary atrum
• Child 12-17 years: Apply 1–2 drops up to 4 times a day as required for a maximum of 7 days, to be instilled into each nostril, administer ephedrine 0.5% nasal drops.
• Adult: Apply 1–2 drops up to 4 times a day as required for a maximum of 7 days, to be instilled into each nostril.
A non-specific adrenoceptor agonist.
By mouth for reversible airway obstruction
• Adult: 15–60 mg, three times daily
By intranasal administration for nasal congestion, sinusitis affecting the maxillary antrum
• Over 12 years: apply 1–2 drops up to four times per day in each nostril for a maximum of seven days
A non-specific adrenoceptor agonist.
By mouth for reversible airway obstruction
• Adult: 15–60 mg, three times daily
By intranasal administration for nasal congestion, sinusitis affecting the maxillary antrum
• Over 12 years: apply 1–2 drops up to four times per day in each nostril for a maximum of seven days
A non-specific adrenoceptor agonist.
By mouth for reversible airway obstruction
• Adult: 15–60 mg, three times daily
By intranasal administration for nasal congestion, sinusitis affecting the maxillary antrum
• Over 12 years: apply 1–2 drops up to four times per day in each nostril for a maximum of seven days